To provide reference for the aeromedical identification of pilots in the future by discussing the problems in the aeromedical identification of congenital heart disease in pilots.

Domestic and international papers and monographs in this field and related fields.

Forty-seven published papers and reviews were cited.

The aeromedical identification of congenital heart disease in active pilots should require a comprehensive consideration of the time and methods of the treatment of the disease, as well as the risk of adverse events such as cryptogenic stroke, arrhythmia, infective endocarditis or mental disorders after treatment, as well as the risk of air incapacitation. Although studies have shown that patent foramen ovale is associated with stroke, but the asymptomatic patent foramen ovale can be regarded as normal anatomical variation and can be qualified for flight. Congenital heart disease may be associated with different types of arrhythmias, which is one of the three major cardiovascular diseases that cause pilots grounded, and seriously affect the flight safety. Infective endocarditis is also the main cause of morbidity and death of patients. Heart valves with endocarditis may have functional changes in a short period of time and those would result in deterioration of cardiac function and poor prognosis. In addition, pilots need to have better psychological quality. Timely and effective psychological counseling or drug treatment can avoid unnecessary grounding.

The diagnosis and treatment of congenital heart disease and aeromedical identification of pilots need to be worked out jointly by cardiologists and the Aeromedical Identification Committee to ensure flight safety and combat effectiveness of the armed forces.

Congenital heart disease; Eligibility determination; Aeromedical identification; Pilots